Table 3 The comparison of clinical parameters between 3D planning group and 2D planning group group patients in LHHs patients

Age (years)

43.8±8.8(28-57)

43.2±7.9(31-60)

0.766

Mean max diameter (cm)

7.5±1.7(5-12.5)

7.2±1.3(5.1-10.8)

0.451

Volume of tumor (ml)

148.2±89.1 (26.8-301.1)

128.4±71.4(39.8-375.8)

0.352

Aspiration blood volume (ml)

108.4±84.9 (14-284)

108.5±75.9(21-359)

0.996

Ablation power (J)

87407.2.9±50387.0(3000-226400)

117775.8±46245.6(6000-200800)

0.021*

Ablation time (s)

1152.0±403.9(600-1890)

1379.7±375.8(810-2230)

0.031*

Antenna insertion

4.8±1.9(2-9)

4.1±1.2(2-6)

0.068

Complete ablation rate (%)

97.7±2.4(93-100)

94.5±3.7(90-100)

0.0004*

Reduction rate of volume (%)

53.4±7.5(43.5-76.0)

51.1±9.0(35.2-76.7)

0.299

Case of hemoglobinuria (No.)

8/17

19/14

0.047*

ALT-pre(U/L)

20.3±15.2(6.9-84.0)

24.7±18.0(9.0-107.5)

0.330

AST-pre(U/L)

19.2±6.5(11.8-38.6)

18.9±7.4(10.8-34.6)

0.872

ALP-pre(U/L)

63.0±18.1(40.4-98.8)

65.2±15.4(39.8-94.3)

0.618

GGT-pre(U/L)

23.5±16.6(8.6-38.1)

24.8±11.0(6.7-48.2)

0.709

Cre-pre(umol/L)

63.0±8.9 (49.9-78.7)

57.2±15.1(37.6-85.9)

0.092

BUN-pre(mmol/L)

4.7±1.2(2.8-7.8)

4.2±1.0(2.6-6.4)

0.055

STB-pre (U/L)

12.3±3.6(6.4-20.1)

12.4±5.3(5.4-26.3)

0.923

DBIL-pre (U/L)

4.5±1.3(2.3-7.5)

5.2±1.5(2.9-7.9)

0.070

ALT-post (U/L)

126.7±56.4(37.0-224.1)

210.9±96.2(94.8-345.0)

0.0002*

AST-post (U/L)

141.0±60.8(40.2-237.0)

211.4±90.0(32-294.5)

0.001*

ALP-post(U/L)

57.3±17.6(34.6-79.4)

80.8±41.9(36.4-178.0)

0.010*

GGT-post(U/L)

26.5±17.6(9.4-64.2)

37.8±19.1(8.8-92.8)

0.060

Cre-post(umol/L)

66.6±16.6(51.3-117.0)

84.5±39.6(40.8-204.0)

0.037*

BUN-post(mmol/L)

4.4±2.6(1.3-13.8)

6.6±5.3(2.4-18.1)

0.061

STB-post (U/L)

28.0±14.4(8.7-70.7)

32.4±14.2(3.8-74.1)

0.252

DBIL-post (U/L)

8.4±4.6 (1.2-17.7)

10.6±10.0(3.4-49.4)

0.428